Exercise and Gastrointestinal Health: New Systematic Review Reveals Dose-Dependent Effects Original paper

What was reviewed?

This systematic review examined the complex bidirectional relationship between exercise and gastrointestinal (GI) health, synthesizing evidence from 231 studies to explore the prevalence, mechanisms, risk factors, and management strategies associated with exercise-induced GI disorders. The review comprehensively analyzed how different types, intensities, and durations of physical activity affect GI function across various populations and conditions. It investigated both the beneficial effects of moderate exercise—including enhanced intestinal motility, reduced systemic inflammation, improved gut barrier integrity, and positive modulation of the gut microbiota—and the detrimental effects of high-intensity or prolonged exercise, such as splanchnic hypoperfusion, increased intestinal permeability (“leaky gut”), and exacerbation of symptoms in individuals with pre-existing GI conditions. The review also examined the role of the gut-brain axis, dietary factors, hydration status, and individual variability in shaping exercise responses, providing a holistic understanding of how exercise and gastrointestinal health interact in clinical and athletic contexts.

Who was reviewed?

The review synthesized data from diverse study populations, including athletes (endurance runners, cyclists, triathletes, swimmers, CrossFit participants, and resistance-trained individuals), recreational exercisers, and sedentary individuals across various age groups. It encompassed studies on special populations including female athletes (with consideration of menstrual cycle effects), older adults with age-related GI changes, and individuals with pre-existing GI conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), diverticular disease, GI cancers, and constipation. The included studies employed randomized controlled trials, cohort studies, case-control studies, and cross-sectional designs, ensuring comprehensive coverage of both mechanistic and clinical outcomes. The review also examined research on elite athletes versus recreational exercisers, highlighting differences in GI symptom prevalence based on training intensity, nutritional practices, and psychological stressors. This broad scope allows for nuanced understanding of how exercise and gastrointestinal health interactions vary across populations.

Most important findings

The review’s most significant contribution is its demonstration that exercise exerts dose-dependent effects on GI health, with moderate-intensity activity providing protective benefits while high-intensity or prolonged exercise can induce significant GI distress. The key findings are summarized below:

Microbiome-related findings: Moderate exercise promotes a diverse and balanced gut microbiota, increasing beneficial bacteria such as Bifidobacterium, Faecalibacterium prausnitzii, and Akkermansia muciniphila. These microbes produce short-chain fatty acids (SCFAs), particularly butyrate, which serves as the primary energy source for colonocytes, enhances tight junction integrity, and exerts anti-inflammatory effects by inhibiting nuclear factor-kappa B signaling. Butyrate also activates the mTOR signaling pathway, potentially linking gut health to muscle protein synthesis through the gut-muscle axis. Conversely, high-intensity exercise, especially when combined with heat stress or dehydration, can lead to dysbiosis, characterized by reduced microbial diversity and increased intestinal permeability. This allows lipopolysaccharides (LPS) from gram-negative bacteria to translocate into circulation, triggering systemic inflammation through elevated pro-inflammatory cytokines (TNF-α, IL-6). The gut-brain axis plays a crucial role, with mind-body exercises like yoga and Tai Chi effectively reducing stress-induced GI symptoms by attenuating hypothalamic-pituitary-adrenal (HPA) axis hyperactivity and modulating neurotransmitters like serotonin.

Prevalence data: Up to 70% of endurance athletes experience GI symptoms during prolonged events, with “runner’s trots” affecting a significant proportion. High-intensity interval training (HIIT) participants report nausea, cramping, and bloating due to rapid blood flow redistribution. In collegiate American football players, 61% reported GI symptoms during exercise, with protein supplement use linked to higher prevalence. Exercise-induced transient abdominal pain (“stitch”) affects up to 18% of recreational runners, particularly younger athletes consuming food or drinks shortly before exercise. Female athletes report higher symptom prevalence due to hormonal influences, with progesterone in the luteal phase slowing gastric emptying and increasing bloating.

Mechanistic insights: Splanchnic hypoperfusion during intense exercise reduces GI blood flow by 50-80%, causing ischemia that damages epithelial tight junctions. Core temperature elevation and reactive oxygen species production exacerbate tight junction disruption. Prolonged or repeated ischemia can cause mucosal erosion, leading to GI bleeding in 8-30% of marathon runners. Dietary factors significantly modulate these effects: high-fat meals delay gastric emptying, high-fiber foods increase gas production, and inadequate hydration intensifies splanchnic hypoperfusion. NSAID use, common among athletes, compounds mucosal injury by inhibiting prostaglandin synthesis. The review emphasizes that individual factors—fitness level, genetic predisposition, gut microbiota composition, and pre-existing GI conditions—substantially influence susceptibility to exercise-induced GI symptoms, underscoring the need for personalized approaches to exercise and gastrointestinal health.

Key implications

This systematic review provides clinicians with a comprehensive framework for understanding and managing the complex relationship between exercise and gastrointestinal health. The most important clinical takeaway is the dose-dependent nature of exercise effects: moderate-intensity physical activity should be recommended as a therapeutic intervention for various GI conditions, while patients engaging in high-intensity or endurance exercise require careful monitoring and preventive strategies. For patients with GERD, moderate aerobic activities like walking and cycling, performed at least two hours after meals, can reduce intra-abdominal pressure and support weight management, whereas high-impact exercises or activities involving bending should be avoided. In IBS, low-to-moderate intensity aerobic exercise and mind-body practices like yoga effectively alleviate symptoms by modulating the gut-brain axis and reducing stress, but vigorous exercise may worsen symptoms in sensitive individuals. For IBD patients, moderate exercise during remission reduces inflammation, fatigue, and improves quality of life, while high-intensity activity during flares should be avoided.

The review’s microbiome findings have practical implications: recommending a combination of aerobic exercise and dietary strategies (adequate fiber, prebiotics, and possibly probiotics) may optimize gut microbial diversity and SCFA production, enhancing gut barrier function and reducing systemic inflammation. The gut-muscle axis concept suggests that butyrate-producing bacteria may support training adaptation, offering a rationale for microbiome-targeted interventions in athletes. For female patients, acknowledging menstrual cycle effects—planning intense training during the follicular phase when GI motility is less impaired—can minimize symptoms. In older adults, low-impact activities like walking and swimming improve gut motility without ischemic risks.

Clinically significant is the recognition that up to 70% of endurance athletes experience GI symptoms, which can impair performance and, in severe cases, lead to ischemic colitis or GI bleeding. Preventive strategies include: (1) dietary adjustments—consuming low-fat, low-fiber meals 3-4 hours before exercise, avoiding high-fiber foods 24-48 hours before events, and using liquid nutrition when solid foods are poorly tolerated; (2) hydration optimization—using oral rehydration solutions with electrolytes during prolonged exercise to maintain splanchnic perfusion and prevent hyponatremia; (3) gradual training progression—allowing GI adaptation to ischemic and mechanical stresses; (4) judicious use of pharmacological interventions—anti-diarrheals (loperamide) for race-day symptom control, antacids for reflux, and probiotics (Lactobacillus, Bifidobacterium strains) for maintaining gut barrier function; and (5) NSAID avoidance before intense exercise.

The review also highlights critical research gaps: long-term effects of chronic high-intensity training on gut health, personalized nutrition and hydration strategies based on individual microbiome profiles, optimal probiotic strains for athletes, and large-scale randomized controlled trials with standardized protocols. For clinicians, this means that while current evidence supports recommending moderate exercise for GI health, interventions for athletes and patients with GI conditions should be individualized, combining exercise prescription with dietary counseling, stress management, and careful monitoring of symptoms. This systematic approach can help patients harness the benefits of physical activity while minimizing GI distress, ultimately improving both digestive health and quality of life.